q-bio.GNApr 18, 2026

Quantum AI for Cancer Diagnostic Biomarker Discovery

Authors: Mandeep Kaur Saggi, Amandeep Singh Bhatia, Humaira Gowher, Sabre Kais

Organizations: Department of Electrical and Computer Engineering, North Carolina State University, NC, USA · Department of Biochemistry, Purdue University, IN, USA · Department of Chemistry, North Carolina State University, Raleigh, NC 27695

Abstract

Quantum machine learning offers a promising new paradigm for computational biology by leveraging quantum mechanical principles to enhance cancer classification, biomarker discovery, and bioinformatics diagnostics. In this study, we apply QML to identify subtype specific biomarkers for lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), the two predominant forms of non-small cell lung cancer. Our methodology involves a two-phase process: in Phase 1, differential expression analysis and methylation analysis between tumor and normal samples allows us to identify LUAD-specific and LUSC-specific genes, revealing potential prognostic biomarkers for cancer subtypes. Phase 2 focuses on developing a quantum classifier capable of distinguishing between LUAD and LUSC tumors, as well as between tumor and normal samples. This classifier not only enhances diagnostic precision but also demonstrates the quantum advantage in processing large-scale multiomic datasets. Our results consistently demonstrated that Sample3, representing the combined gene set, achieved the highest overall predictive performance in all metrics. These results demonstrate that QML provides an effective and scalable approach for biomarker discovery and subtype specific cancer classification. GO enrichment analysis highlighted the significant involvement of genes in synaptic signaling, ion channel regulation, and neuronal development. In the quantum phase, KEGG analysis further identified enrichment in cancer-associated pathways, including neurotrophin, MAPK, Ras, and PI3KAkt signaling, with key genes such as NGFR, NTRK2, and NTF3 suggesting a central role in neurotrophinmediated oncogenic processes. Our findings highlight the growing potential of quantum computing to advance precision oncology and next-generation biomedical analytics.

Explore similar work

CardsList
Apr 18, 2026quant-ph

Hybrid Quantum Neural Networks for Enhanced Breast Cancer Thermographic Classification: A Novel Quantum-Classical Integration Approach

Breast cancer diagnosis through thermographic image analysis remains a critical challenge in medical AI, with classical deep learning approaches facing limitations in complex thermal pattern classification tasks. This paper presents a novel Hybrid Quantum Neural Network (HQNN) architecture that integrates quantum computing principles with classical convolutional neural networks for enhanced breast cancer classification. Our approach employs parameterized quantum circuits with multi-head attention mechanisms for quantum-aware feature encoding, coupled with classical convolutional layers for comprehensive pattern recognition. The quantum component utilizes a 4qubit variational circuit with strongly entangling layers, while the classical component incorporates advanced attention mechanisms for feature fusion. Experimental validation on breast cancer thermographic data demonstrates substantial performance improvements over state-of-the-art classical architectures, with the quantum-enhanced approach exhibiting superior convergence dynamics and enhanced feature representation capabilities. Our findings provide evidence for quantum advantage in medical image classification through classical simulation, establishing a framework for quantum-classical hybrid systems in healthcare applications. The methodology addresses key challenges in quantum machine learning deployment while maintaining computational feasibility on near-term quantum devices.
Riza Alaudin Syah, Irwan Alnarus Kautsar, Gunawan Witjaksono +1
Hybrid Quantum Neural NetworksMammographyNon-Small Cell Lung CancerThermal Imaging
AskPDF
Apr 24, 2026cs.CV

On the Complementarity of Quantum and Classical Features: Adaptive Hybrid Quantum-Classical Feature Fusion for Breast Cancer Classification

The integration of quantum machine learning with classical deep learning offers promising avenues for medical image analysis by mapping data into high-dimensional Hilbert spaces. However, effectively unifying these distinct paradigms remains challenging due to common optimization asymmetries. In this paper, a novel hybrid quantum-classical architecture for breast cancer diagnosis based on a dual-branch feature-extraction pipeline is proposed. Our framework extracts and unifies complementary representations from classical models and quantum circuits, exploring both trainable and deterministic (non-trainable) quantum paradigms. To integrate these embeddings, three progressive feature fusion strategies are introduced: Static Hybrid Fusion (SHF) for offline extraction, Dynamic Hybrid Fusion (DHF) for end-to-end co-adaptation, and a novel Temperature-Scaled Hybrid Fusion (TSHF). The TSHF strategy incorporates a learnable scalar, inspired by multimodal learning, that dynamically balances hybrid gradient dynamics and resolves optimization bottlenecks. Empirical validation on the BreastMNIST dataset confirms our hypothesis that unifying diverse feature representations creates a richer data context. The TSHF strategy, specifically when pairing a ResNet backbone with a trainable quantum circuit, achieved a peak accuracy of 87.82%, F1-score of 91.77%, and an AUC-ROC of 89.08%, outperforming purely classical baselines. These results demonstrate that the proposed hybrid framework improves classification accuracy and threshold reliability, providing a stable, high-performance architecture for the clinical deployment of quantum-enhanced diagnostic tools.
Yasmin Rodrigues Sobrinho, João Renato Ribeiro Manesco, João Paulo Papa
Hybrid Quantum Neural NetworksMammographyFeature FusionFusion
AskPDF
Jul 13, 2026quant-ph

\mathtt{Q^2SAR}: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learning

Quantitative Structure-Activity Relationship (QSAR\mathtt{QSAR}) modeling is a foundational computational methodology in early-stage drug discovery, heavily relied upon for predicting compound toxicity, bioavailability, and therapeutic potential. However, classical methods often struggle to effectively map the highly complex, non-linear, and high-dimensional interactions inherent in molecular data, leading to reduced predictive accuracy and costly late-stage clinical failures. In this paper, we present a Quantum Multiple Kernel Learning (QMKL\mathtt{QMKL}) framework, dubbed Next-Gen Q2SAR\mathtt{Q^2SAR}, that leverages Quantum Support Vector Machines (QSVMs\mathtt{QSVMs}) to overcome these classical limitations. By encoding molecular descriptors into exponentially large quantum Hilbert spaces, our approach substantially enhances the expressiveness of non-linear modeling. Benchmarking our quantum-enhanced framework on a dataset targeting the DYRK1A\mathtt{DYRK1A} kinase (a critical target for Alzheimer's disease), the QMKL\mathtt{QMKL}-SVM\mathtt{SVM} achieves an impressive Area Under the Curve (AUC\mathtt{AUC}) score of 0.87500.8750, significantly outperforming classical state-of-the-art Gradient Boosting models (AUC=0.8037\mathtt{AUC} = 0.8037). Furthermore, we establish a theoretical and empirical pathway toward resolving classical data bottlenecks through projected quantum kernels (PQK\mathtt{PQK}) and measurement accelerators. As quantum computing architecture matures, this framework paves the way for autonomous cognitive architectures and self-improving drug discovery pipelines, promising to unlock deeper insights across vast chemical spaces and to accelerate the development of life-saving therapeutics.
Mariano Caruso, Daniel Ruiz, Alejandro Giraldo +1
Quantum KernelsDrug DiscoveryStructure-Based Drug DesignQuantum ComputingConcept Bottleneck Models
AskPDF